Drug Type Small molecule drug |
Synonyms- |
Target |
Action antagonists |
Mechanism FGFR4 antagonists(Fibroblast growth factor receptor 4 antagonists) |
Therapeutic Areas |
Active Indication- |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseSuspendedPhase 1 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Advanced Malignant Solid Neoplasm | Phase 1 | China | 18 Apr 2024 | |
| Biliary Tract Neoplasms | IND Application | China | 17 Jan 2020 | |
| Hepatocellular Carcinoma | IND Application | China | 17 Jan 2020 |





